Atrioventricular block is classified as congenital if diagnosed in utero, at birth, or within the
first month of life. The pathophysiological process is believed to be due to immune-mediated …

The potential benefits of fetal cardiac intervention (FCI) have been realized for many years.
In 1975, Eibschitz et al1 reported intrapartum treatment of fetal ventricular tachycardia by …

The human fetal heart develops arrhythmias and conduction disturbances in response to
ischemia, inflammation, electrolyte disturbances, altered load states, structural defects …

The majority of congenital cardiovascular disease including structural cardiac defects,
abnormalities in cardiac function, and rhythm disturbances can be identified prenatally using …

Combination products with a wide range of clinical applications represent a unique class of
medical products that are composed of more than a singular medical device or …

Congenital complete heart block (CCHB) is a life‐threatening medical condition in the
unborn fetus with insufficiently validated prenatal interventions. Maternal administration of …

The incidence of congenital atrioventricular (AV) block is between 1 in 15,000 and 1 in
20,000 births. It may occur in isolation or as a consequence of anomalous development of …

Highly Commended at the British Medical Association Book Awards 2016 The third edition
of Anesthesia for Congenital Heart Disease, the recognized gold-standard reference in this …

One hundred twenty years have elapsed since Morquio 1 first reported heart block in several
members of the same family. Since that time, congenital heart block has been reported and …

Over the years, Fetal Cardiology have been incorporated into the daily practice of Pediatric
Cardiology. What was once restricted to a few fetal heart researchers, has slowly been …